dc.contributor.author | Goswami, Pushpendra | |
dc.contributor.author | Oliva, Esther | |
dc.contributor.author | Ionova, Tatyana | |
dc.contributor.author | Else, R | |
dc.contributor.author | Kell, J | |
dc.contributor.author | Fielding, AK | |
dc.contributor.author | Jennings, DM | |
dc.contributor.author | Karakantza , M | |
dc.contributor.author | Al-Ismail, S | |
dc.contributor.author | Lyness, J | |
dc.contributor.author | Collins, GP | |
dc.contributor.author | McConnell , S | |
dc.contributor.author | Langton, C | |
dc.contributor.author | Al-Obaidi, MJ | |
dc.contributor.author | Oblak, M | |
dc.contributor.author | Salek, Mir-Saeed Shayegan | |
dc.date.accessioned | 2019-05-09T14:06:02Z | |
dc.date.available | 2019-05-09T14:06:02Z | |
dc.date.issued | 2019-04-30 | |
dc.identifier.citation | Goswami , P , Oliva , E , Ionova , T , Else , R , Kell , J , Fielding , AK , Jennings , DM , Karakantza , M , Al-Ismail , S , Lyness , J , Collins , GP , McConnell , S , Langton , C , Al-Obaidi , MJ , Oblak , M & Salek , M-S S 2019 , ' Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study. ' , Journal of Comparative Effectiveness Research , vol. 8 , no. 7 , pp. 523-533 . https://doi.org/10.2217/cer-2018-0108 | |
dc.identifier.issn | 2042-6305 | |
dc.identifier.other | PURE: 16689222 | |
dc.identifier.other | PURE UUID: 5ef845f3-90a9-4dbd-abbe-8a9726b02b6c | |
dc.identifier.other | Scopus: 85065670913 | |
dc.identifier.uri | http://hdl.handle.net/2299/21319 | |
dc.description | © 2019 Goswami, Oliva, Ionova et al. | |
dc.description.abstract | Aim:To determine measurement equivalence of paper and electronic application of the hematologi-cal malignancy-patient-reported outcome (HM-PRO), a specific measure for the evaluation of patient-reported outcomes in HMs.Patients & methods:Following International Society of Pharmacoeconomicsand Outcomes Research ePRO Good Research Practice Task Force guidelines, a total of 193 adult patientswith different HMs were recruited into a multicenter prospective study. The paper and the electronic ver-sion of the instrument were completed in the outpatient clinics in a randomized crossover design with a30-min time interval to minimize the learning effect. Those who completed the paper version first, com-pleted the electronic version after 30 min and vice versa. Instrument version and order effects were testedon total score of the two parts of the HM-PRO (Part A: quality of life and Part B: signs & symptoms) in atwo-way ANOVA with patients as random effects. Intraclass correlation coefficients (95% CI) and Spear-man’s rank correlation coefficients were used to evaluate test–retest reliability and reproducibility. Theeffects of instrument version and order were tested on total score of the two parts of HM-PRO.Results:The questionnaire version and administration order effects were not significant at the 5% level. Therewere no interactions found between these two factors for HM-PRO (Part A [quality of life]; p=0.95); and(part B [signs and symptoms]; p=0.72]. Spearman’s rank correlation coefficients were greater than 0.9, andintraclass correlation coefficients ranged from 0.94 to 0.98; furthermore, the scores were not statisticallydifferent between the two versions, showing acceptable reliability indexes. Noteworthy, the differencebetween the completion time for both paper (mean=6:38 min) and electronic version (mean=7:29 min)was not statistically significant (n=100; p=0.11). Patients did not report any difficulty in completing theelectronic version during cognitive interviews and were able to understand and respond spontaneously.Conclusion:Measurement equivalence has been demonstrated for the paper and electronic applicationof the HM-PRO. | en |
dc.format.extent | 11 | |
dc.language.iso | eng | |
dc.relation.ispartof | Journal of Comparative Effectiveness Research | |
dc.subject | HM-PRO | |
dc.subject | hematological malignancy | |
dc.subject | paper/electronic PRO | |
dc.subject | Health Policy | |
dc.title | Paper and electronic versions of HM-PRO, a novel patient-reported outcome measure for hematology: an equivalence study. | en |
dc.contributor.institution | School of Life and Medical Sciences | |
dc.contributor.institution | Department of Clinical and Pharmaceutical Sciences | |
dc.contributor.institution | Centre for Health Services and Clinical Research | |
dc.contributor.institution | Public Health and Patient Safety Unit | |
dc.description.status | Peer reviewed | |
dc.identifier.url | http://www.scopus.com/inward/record.url?scp=85065670913&partnerID=8YFLogxK | |
rioxxterms.version | VoR | |
rioxxterms.versionofrecord | https://doi.org/10.2217/cer-2018-0108 | |
rioxxterms.type | Journal Article/Review | |
herts.preservation.rarelyaccessed | true | |